Literature DB >> 10884921

Localisation of HHV-8 in AIDS related lymphadenopathy.

J J O'Leary1, M Kennedy, K Luttich, V Uhlmann, I Silva, J Russell, O Sheils, M Ring, M Sweeney, C Kenny, N Bermingham, C Martin, M O'Donovan, D Howells, S Picton, S B Lucas.   

Abstract

BACKGROUND: Many lymph node abnormalities have been described in AIDS. These include opportunistic infections that sometimes result in spindle cell pseudotumours, Kaposi's sarcoma (KS), malignant lymphoma (Hodgkin's and non-Hodgkin's), and florid reactive hyperplasia. Among these, reactive hyperplasia is the most common manifestation of AIDS related lymphadenopathy. AIM: To examine whether human herpesvirus 8 (HHV-8), the aetiological agent of KS, can be localised in AIDS related lymphadenopathy and whether its appearance in such nodes is predictive of Kaposi's sarcoma development.
METHODS: A series of human immunodeficiency virus (HIV) positive men (n = 21) with AIDS related lymphadenopathy who at the time of presentation had KS or subsequently developed KS (n = 5) were examined. The prevalence of HHV-8 was assessed in these patients using solution phase polymerase chain reaction (PCR), real time TaqMan quantitative PCR, and in cell amplification techniques (PCR in situ hybridisation (PCR-ISH) and labelled primer driven in cell amplification).
RESULTS: Using standard solution phase PCR in a nested format, only two of the 21 patients with AIDS related lymphadenopathy were positive for HHV-8. The lymph node of one of these patients contained KS lesions. Three HHV-8 positive patients were identified using TaqMan PCR (the original two positive patients and one additional patient). All of the positive patients either subsequently developed KS (n = 2) or had KS at the time of diagnosis (n = 1). Two additional patients subsequently developed KS, but were negative for HHV-8 by solution phase PCR and TaqMan PCR. Using PCR-ISH, HHV-8 amplicons were identified in some lymphoid cells (in one patient) and in spindle cells of the KS lesion in another. The positive lymphoid cells were predominantly concentrated in B cell areas of the affected lymph nodes, confirming the B cell tropism exhibited by HHV-8.
CONCLUSIONS: The presence of HHV-8 in AIDS related lymphadenopathy is predictive of KS development and probably represents seeding of HHV-8 infected B cells from the peripheral blood. These findings support a role for HHV-8 in the pathobiology of KS.

Entities:  

Mesh:

Year:  2000        PMID: 10884921      PMCID: PMC1186901          DOI: 10.1136/mp.53.1.43

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  19 in total

1.  Spindle cell pseudotumor due to Mycobacterium avium-intracellulare in patients with acquired immunodeficiency syndrome (AIDS). Positive staining of mycobacteria for cytoskeleton filaments.

Authors:  J Umlas; M Federman; C Crawford; C J O'Hara; J S Fitzgibbon; A Modeste
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

Review 2.  AIDS-related lymphadenopathies.

Authors:  J W Said
Journal:  Semin Diagn Pathol       Date:  1988-11       Impact factor: 3.464

Review 3.  The lymphadenopathy of HIV infection.

Authors:  C D Baroni; S Uccini
Journal:  Am J Clin Pathol       Date:  1993-04       Impact factor: 2.493

4.  Hypervascular follicular hyperplasia and Kaposi's sarcoma in patients at risk for AIDS.

Authors:  N L Harris
Journal:  N Engl J Med       Date:  1984-02-16       Impact factor: 91.245

5.  HHV8 and female Kaposi's sarcoma.

Authors:  M M Kennedy; S B Lucas; R Russell-Jones; D D Howells; S J Picton; A Bardon; I L Comley; J O McGee; J J O'Leary
Journal:  J Pathol       Date:  1997-12       Impact factor: 7.996

6.  Interphase cytogenetics using biotin and digoxigenin labelled probes I: relative sensitivity of both reporter molecules for detection of HPV16 in CaSki cells.

Authors:  C S Herrington; J Burns; A K Graham; M Evans; J O McGee
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

7.  Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines.

Authors:  C S Herrington; A K Graham; J O McGee
Journal:  J Clin Pathol       Date:  1991-01       Impact factor: 3.411

8.  The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related and non-human immunodeficiency virus-related lymphadenopathy syndromes.

Authors:  C J O'Hara; J E Groopman; M Federman
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

9.  The immunohistology of follicle lysis in lymph node biopsies from homosexual men.

Authors:  G S Wood; C F Garcia; R F Dorfman; R A Warnke
Journal:  Blood       Date:  1985-11       Impact factor: 22.113

10.  Lymphocyte status of lymph node and blood in acquired immunodeficiency syndrome (AIDS) and AIDS-related complex disease.

Authors:  H J Schuurman; P M Kluin; F H Gmelig Meijling; J A Van Unnik; L Kater
Journal:  J Pathol       Date:  1985-12       Impact factor: 7.996

View more
  4 in total

Review 1.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

3.  Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens.

Authors:  F R Stamey; M M Patel; B P Holloway; P E Pellett
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Authors:  Francesco Broccolo; Giuseppe Locatelli; Loredana Sarmati; Sara Piergiovanni; Fabrizio Veglia; Massimo Andreoni; Stefano Buttò; Barbara Ensoli; Paolo Lusso; Mauro S Malnati
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.